Clinical Trials in Pennsylvania

Showing 9661-9680 of 19,675 trials

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

NCT04415606

QuikClot Control+ Hemostatic Dressing (QuikClot+) is indicated for temporary control of internal organ space bleeding for patients displaying Class III or Class IV Bleeding. It may also be used for control of severely bleeding wounds such as surgical wounds and traumatic injuries. QuikClot Control+ is also indicated for temporary control of mild to moderate bleeding in cardiac surgical procedures. QuikClot Control+ is also indicated for use to control bleeding from bone surface following sternotomy.

Hemostasis

Z-Medica266 participantsStarted Jun 2020

Aurora, Colorado, United States • Atlanta, Georgia, United States • Pocatello, Idaho, United States +4 more locations

UNKNOWN37 miles

Pilot Testing of Food Images in Children

NCT03338634

This is a single, un-replicated visit to the Children's Metabolic Kitchen and Eating Behavior Lab designed to gather data on children's responses to images used in MRI studies. Additionally, a demographic questionnaire for parents will be piloted.

Childhood ObesityfMRI

Penn State University400 participantsStarted Oct 2017

University Park, Pennsylvania, United States

COMPLETEDPhase 282 miles

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

NCT00628095

CE-224,535 is known to block a chemical that acts as a gateway to some of your immune cells. Blocking this gateway prevents the cells from pushing out 2 chemicals called IL-1 and IL-18 that are known to cause some of the inflammation seen in rheumatoid arthritis. It is hoped that taking this drug will reduce the symptoms of rheumatoid arthritis

Arthritis, Rheumatoid

Pfizer100 participantsStarted Apr 2008

Mesa, Arizona, United States • DeBary, Florida, United States • Lake Mary, Florida, United States +24 more locations

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

Pilot Testing of Food Images in Children

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

Find Trials by Condition in Pennsylvania

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

A Study of Oral Contraception Under Simulated OTC Conditions

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Immunotherapy Study for Metastatic Renal Cell Cancer

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

COVID-19 Vaccines Safety Tracking (CoVaST)

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Neuroimaging Biomarker for Seizures

Parents Advancing Toddler Health

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers